| SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study AG Letizia, Y Ge, S Vangeti, C Goforth, DL Weir, NA Kuzmina, ... The Lancet Respiratory Medicine 9 (7), 712-720, 2021 | 176 | 2021 |
| SARS-CoV-2 transmission among marine recruits during quarantine AG Letizia, I Ramos, A Obla, C Goforth, DL Weir, Y Ge, MM Bamman, ... New England Journal of Medicine 383 (25), 2407-2416, 2020 | 129 | 2020 |
| Hendra virus and Nipah virus animal vaccines CC Broder, DL Weir, PA Reid Vaccine 34 (30), 3525-3534, 2016 | 105 | 2016 |
| Enhanced autophagy contributes to reduced viral infection in black flying fox cells ED Laing, SL Sterling, DL Weir, CR Beauregard, IL Smith, SE Larsen, ... Viruses 11 (3), 260, 2019 | 38 | 2019 |
| Recent observations on Australian bat lyssavirus tropism and viral entry DL Weir, EJ Annand, PA Reid, CC Broder Viruses 6 (2), 909-926, 2014 | 33 | 2014 |
| Asymptomatic SARS-CoV-2 infection is associated with higher levels of serum IL-17C, matrix metalloproteinase 10 and fibroblast growth factors than mild symptomatic COVID-19 A Soares-Schanoski, N Sauerwald, CW Goforth, S Periasamy, DL Weir, ... Frontiers in Immunology 13, 821730, 2022 | 32 | 2022 |
| Host cell virus entry mediated by Australian bat lyssavirus G envelope glycoprotein occurs through a clathrin-mediated endocytic pathway that requires actin and Rab5 DL Weir, ED Laing, IL Smith, LF Wang, CC Broder Virology journal 11, 1-10, 2014 | 29 | 2014 |
| SARS-CoV-2 seropositivity among US marine recruits attending basic training, United States, spring–fall 2020 AG Letizia, Y Ge, CW Goforth, DL Weir, R Lizewski, S Lizewski, ... Emerging Infectious Diseases 27 (4), 1188, 2021 | 19 | 2021 |
| Host cell tropism mediated by Australian bat lyssavirus envelope glycoproteins DL Weir, IL Smith, KN Bossart, LF Wang, CC Broder Virology 444 (1-2), 21-30, 2013 | 13 | 2013 |
| Report of a Strain of Staphylococcus caprae with the Genes for Enterotoxin A and Enterotoxin-Like Toxin Type P D Weir, C Jones, L Ammerman, K Dybdahl, S Tomlinson Journal of clinical microbiology 45 (10), 3476-3477, 2007 | 12 | 2007 |
| SARS-CoV-2 outbreak dynamics in an isolated US military recruit training center with rigorous prevention measures RA Lizewski, RSG Sealfon, SW Park, GR Smith, CK Porter, ... Epidemiology 33 (6), 797-807, 2022 | 11 | 2022 |
| A methylation clock model of mild SARS‐CoV‐2 infection provides insight into immune dysregulation W Mao, CM Miller, VD Nair, Y Ge, MAS Amper, A Cappuccio, MC George, ... Molecular Systems Biology 19 (5), e11361, 2023 | 10 | 2023 |
| Viable virus shedding during SARS-CoV-2 reinfection AG Letizia, DR Smith, Y Ge, I Ramos, RSG Sealfon, C Goforth, ... The Lancet. Respiratory Medicine 9 (7), e56, 2021 | 10 | 2021 |
| Memory B-cell development after asymptomatic or mild symptomatic SARS-CoV-2 infection Y Kato, NI Bloom, P Sun, CA Balinsky, Q Qiu, Y Cheng, V Jani, ... The Journal of infectious diseases 227 (1), 18-22, 2023 | 9 | 2023 |
| Antibody responses to SARS-CoV-2 following an outbreak among marine recruits with asymptomatic or mild infection I Ramos, C Goforth, A Soares-Schanoski, DL Weir, EC Samuels, S Phogat, ... Frontiers in immunology 12, 681586, 2021 | 9 | 2021 |
| Pre-infection antiviral innate immunity contributes to sex differences in SARS-CoV-2 infection N Sauerwald, Z Zhang, I Ramos, VD Nair, A Soares-Schanoski, Y Ge, ... Cell Systems 13 (11), 924-931. e4, 2022 | 8 | 2022 |
| Isolation and characterization of cross-reactive human monoclonal antibodies that potently neutralize Australian bat Lyssavirus variants and other phylogroup 1 Lyssaviruses DL Weir, SAA Coggins, BK Vu, J Coertse, L Yan, IL Smith, ED Laing, ... Viruses 13 (3), 391, 2021 | 8 | 2021 |
| SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study. Lancet Respir Med. 2021; 9 (7): 712–20 AG Letizia, Y Ge, S Vangeti, C Goforth, DL Weir, NA Kuzmina Epub 2021/04/19. https://doi. org/10.1016/S2213-2600 (21) 00158-2 PMID: 33865504, 0 | 8 | |
| SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: A prospective cohort study. Lancet Respir Med 9: 712-720 AG Letizia, Y Ge, S Vangeti, C Goforth, DL Weir, NA Kuzmina, ... | 7 | 2021 |
| mAb therapy controls CNS‐resident lyssavirus infection via a CD4 T cell‐dependent mechanism KE Mastraccio, C Huaman, SAA Coggins, C Clouse, M Rader, L Yan, ... EMBO Molecular Medicine 15 (10), e16394, 2023 | 5 | 2023 |
